Immutep has announced positive phase one trial results for a compound that could help treat autoimmune diseases.

This Australian dividend stock is an impressive business for passive income, in my view. The fall of the share price makes it ...

The jump has helped to recover some of the fast food retailers' recent share price losses, albeit there is a long way to go ...

At the start of 2025, shares were trading for approximately $14. Last week, shares closed at $26.40, which represents a rise ...

Will owners of Flight Centre Travel Group Ltd (ASX: FLT) shares see profit soar higher? Let’s take a look at the analyst ...

The team at Bell Potter has upgraded its view on this ASX materials stock after a key contract announcement on Friday.

The ASX All Ords gold stock has raced ahead of the All Ordinaries Index (ASX: XAO) in 2025. Here’s what investors just ...

Lendlease share price in focus as group sells $400m TRX stake, updates on FY26 capital recycling, net debt, and CRU ...

DroneShield shares gained attention due to an update on its governance review, addressing issues from recent controversies ...

Reece increases its on-market share buyback to $85 million, underscoring ongoing capital management discipline and a positive ...

Regis Healthcare shares are in focus after CEO Dr Linda Mellors resigns. Here’s what investors need to know about the ...

As demand for artificial intelligence (AI) remains strong, investors are wondering who the biggest winners will be going into ...